Dhaka [Bangladesh], November 25 (ANI): Bangladesh is expected to get 68 million COVID-19 vaccine doses from the Gavi, the Vaccine Alliance, under the global arrangement called Covax facility within 2021.
Riyadh [Saudi Arabia], November 22 (ANI/Sputnik): The G20 countries have vowed to make efforts to ensure universal access to COVID-19 vaccines, therapeutics and diagnostics, a final statement adopted on Sunday after a two-day G20 summit said.
Bhubaneswar (Odisha) [India], November 21 (ANI): In phase 3, COVAXIN's effectiveness to prevent the disease (coronavirus) will be checked, said Dr. E Venkata Rao, Principal investigator of COVAXIN trial at Institute of Medical Sciences and SUM Hospital, Bhubaneswar, while adding that out
Chandigarh [India], November 20 (ANI): All government and private schools in Haryana will remain closed till November 30 in view of COVID-19 situation, the state government said on Friday.
Ambala (Haryana) [India], November 20 (ANI): Haryana Health Minister Anil Vij was administered a trial dose of Bharat Biotech's COVID-19 vaccine 'Covaxin' at a hospital in Ambala on Friday.
Chandigarh (Haryana) [India], November 19 (ANI): Haryana's health minister, Anil Vij, on Thursday, said that he will be administered a trial dose of 'Covaxin' on November 20.
Rohtak (Haryana) [India], November 19 (ANI): Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences (PGIMS), Rohtak, hopes to get 1,000 healthy volunteers by Thursday for the third-phase trial of Bharat Biotech's COVID-19 vaccine candidate, Covaxin, that will begin from F
New Delhi [India], November 18 (ANI): Haryana Health Minister Anil Vij has offered to become the "first volunteer" for Phase-III clinical trial of Bharat Biotech's COVID-19 vaccine 'Covaxin', which will begin in Haryana from November 20.
New York [US], November 12 (ANI): World Health Organisation (WHO) Director-General Tedros Adhanom Ghebreyesus on Wednesday thanked Prime Minister Narendra Modi for his strong commitment to Covax and making Covid-19 vaccines a global public good.
Bhubaneswar (Odisha) [India], October 26 (ANI): The third phase human trial of indigenously developed COVID-19 vaccine 'Covaxin' will soon commence at the Institute of Medical Sciences (IMS) and SUM Hospital in Odisha.
New Delhi [India], October 23 (ANI): In a major development, Drugs Controller General of India (DCGI) on Friday gave permission to Bharat Biotech for conducting Phase-III clinical trial for the indigenous COVID-19 vaccine - Covaxin.